We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$79.2B
AUM Growth
+$3.07B
(+4%)
Cap. Flow
-$2.3B
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
48.93%
Holding
809
New
117
Increased
205
Reduced
335
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$331M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$327M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$319M |
| 4 |
Allison Transmission
ALSN
|
+$195M |
| 5 |
BA.PRA
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
|
+$50M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$853M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$294M |
| 3 |
NVIDIA
NVDA
|
+$266M |
| 4 |
Netflix
NFLX
|
+$190M |
| 5 |
Meta Platforms (Facebook)
META
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.48% |
| 2 | Consumer Discretionary | 18.83% |
| 3 | Communication Services | 18.1% |
| 4 | Healthcare | 11.79% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.6B
| $14.3M | 0.02% |
133,792
+83,843
| +168% | +$9.17M |
|
302
Garrett Motion
GTX
$5.48B
| $14.3M | 0.02% |
1,579,376
+159,891
| +11% | +$1.33M |
|
303
Atmus Filtration Technologies
ATMU
$4.09B
| $14.2M | 0.02% |
362,228
| – | – |
|
304
AbbVie
ABBV
$433B
| $14.1M | 0.02% |
79,414
+824
| +1% | +$151K |
|
305
Cabot Corp
CBT
$4.47B
| $14M | 0.02% |
153,265
-2,090
| -1% | -$225K |
|
306
ExxonMobil
XOM
$661B
| $14M | 0.02% |
129,817
+18,341
| +16% | +$2.15M |
|
|
CADE
307
DELISTED
Cadence Bank
CADE
| $13.9M | 0.02% |
403,676
-17,009
| -4% | -$598K |
|
308
Bristol-Myers Squibb
BMY
$133B
| $13.9M | 0.02% |
245,168
-32,431
| -12% | -$1.81M |
|
309
Pultegroup
PHM
$24.6B
| $13.8M | 0.02% |
127,144
-24,840
| -16% | -$3.23M |
|
310
Agios Pharmaceuticals
AGIO
$1.93B
| $13.7M | 0.02% |
417,208
-195,158
| -32% | -$9.17M |
|
311
Ceco Environmental
CECO
$4.01B
| $13.5M | 0.02% |
445,352
+61,156
| +16% | +$1.74M |
|
312
Crocs
CROX
$6.68B
| $13.2M | 0.02% |
120,682
-1,338
| -1% | -$156K |
|
313
California Resources
CRC
$4.79B
| $13.2M | 0.02% |
254,680
+6,464
| +3% | +$351K |
|
314
Kyndryl
KD
$2.99B
| $13.1M | 0.02% |
+379,570
| New | +$11M |
|
315
United Parcel Service
UPS
$88.6B
| $13M | 0.02% |
103,068
+5,356
| +5% | +$705K |
|
316
JB Hunt Transport Services
JBHT
$25B
| $13M | 0.02% |
76,135
+2,722
| +4% | +$487K |
|
317
Reliance Steel & Aluminium
RS
$21.8B
| $13M | 0.02% |
48,213
+1,640
| +4% | +$486K |
|
|
SARO
318
StandardAero Inc
SARO
$9.43B
| $12.9M | 0.02% |
+522,221
| New | +$15.1M |
|
319
Haemonetics
HAE
$3.93B
| $12.8M | 0.02% |
163,856
| – | – |
|
320
Avantor
AVTR
$9.27B
| $12.7M | 0.02% |
601,069
-148,644
| -20% | -$3.34M |
|
321
W.R. Berkley
WRB
$26.3B
| $12.6M | 0.02% |
214,926
+3,087
| +1% | +$185K |
|
322
Academy Sports + Outdoors
ASO
$3.03B
| $12.5M | 0.02% |
216,712
+50,842
| +31% | +$2.68M |
|
323
Kemper
KMPR
$1.55B
| $12.3M | 0.02% |
185,611
-2,743
| -1% | -$181K |
|
324
Nexstar Media Group
NXST
$5.94B
| $12.3M | 0.02% |
77,631
+3,009
| +4% | +$505K |
|
325
MDU Resources
MDU
$4.29B
| $12.1M | 0.02% |
672,323
-282,307
| -30% | -$4.95M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q4 2024 Portfolio in Review
As of Q4 2024, Loomis, Sayles & Company held 809 positions worth $79.2B, up 4% from $76.2B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Loomis, Sayles & Company's Q4 2024 filing shows 117 new, 205 increased, 335 reduced and 91 closed positions. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M. The largest sale was Tesla, an estimated $853M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $331M increase.
- Loomis, Sayles & Company's biggest Q4 2024 reduction was Tesla, cutting an estimated $853M.
- Loomis, Sayles & Company fully exited Medpace in Q4 2024, selling an estimated $68.7M.
- Loomis, Sayles & Company's ten largest holdings make up 49% of its $79.2B portfolio in Q4 2024.
- Loomis, Sayles & Company opened 117 new positions and closed 91 in Q4 2024.
- Loomis, Sayles & Company's portfolio value rose 4% quarter-over-quarter to $79.2B.
Based on Loomis, Sayles & Company's 13F filing for Q4 2024, filed 12 Feb 2025.